Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4 - PubMed (original) (raw)
. 1988 Jul-Aug;8(4):531-5.
Affiliations
- PMID: 2902821
Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4
M Volm et al. Anticancer Res. 1988 Jul-Aug.
Abstract
The aim of this investigation was to find out whether resistant cells of different tumors can be detected immunocytochemically by the streptavidin-biotin-peroxidase-complex method using the monoclonal antibody 265/F4. This antibody was prepared against the membrane P-glycoprotein of Mr 170 kd from colchicine-resistant CHO cells. For this purpose the acquired resistance of tissue culture cells, ascites tumors and the acquired and inherent resistance of human lung carcinoma xenografts were analyzed. Doxorubicin-resistant S180 cells, daunorubicin-resistant L1210 cells and vincristine-resistant human epidermoid lung carcinoma xenografts showed an intense positive reaction with the monoclonal antibody. In contrast, no specific immunoreactivity was observed with parental (sensitive) tumor cells. These data could eventually provide a prognostic tool for the detection of resistant human tumor cells.
Similar articles
- Intrinsic and acquired multidrug resistance in human lung carcinomas grown in nude mice.
Mattern J, Bak M, Volm M. Mattern J, et al. Anticancer Res. 1990 Jan-Feb;10(1):177-80. Anticancer Res. 1990. PMID: 1970715 - Reversal of Vinca alkaloid resistance by anti-P-glycoprotein monoclonal antibody HYB-241 in a human tumor xenograft.
Rittmann-Grauer LS, Yong MA, Sanders V, Mackensen DG. Rittmann-Grauer LS, et al. Cancer Res. 1992 Apr 1;52(7):1810-6. Cancer Res. 1992. PMID: 1348013 - Detection of murine S180 cells expressing a multidrug resistance phenotype using different in vitro test systems and a monoclonal antibody.
Volm M, Efferth T, Günther A, Lathan B. Volm M, et al. Arzneimittelforschung. 1987 Jul;37(7):862-7. Arzneimittelforschung. 1987. PMID: 3314882 - [P glycoprotein as a resistance marker in tumors].
Mattern J, Volm M. Mattern J, et al. Dtsch Med Wochenschr. 1989 Dec 1;114(50):1979-81. Dtsch Med Wochenschr. 1989. PMID: 2574661 Review. German. No abstract available.
Cited by
- Detection of P-glycoprotein in human leukemias using monoclonal antibodies.
Mattern J, Efferth T, Bak M, Ho AD, Volm M. Mattern J, et al. Blut. 1989 Apr;58(4):215-7. doi: 10.1007/BF00320777. Blut. 1989. PMID: 2565123 - Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas.
Volm M, Drings P, Wodrich W. Volm M, et al. J Cancer Res Clin Oncol. 1993;119(9):507-10. doi: 10.1007/BF01686458. J Cancer Res Clin Oncol. 1993. PMID: 8100821 - Expression of metallothionein in initial and relapsed childhood acute lymphoblastic leukemia.
Sauerbrey A, Zintl F, Volm M. Sauerbrey A, et al. Ann Hematol. 1994 Sep;69(3):111-5. doi: 10.1007/BF01695690. Ann Hematol. 1994. PMID: 8086505 - P-glycoprotein expression in treated and untreated human breast cancer.
Schneider J, Bak M, Efferth T, Kaufmann M, Mattern J, Volm M. Schneider J, et al. Br J Cancer. 1989 Dec;60(6):815-8. doi: 10.1038/bjc.1989.372. Br J Cancer. 1989. PMID: 2574987 Free PMC article. - Overexpression of P-glycoprotein and glutathione S-transferase-pi in resistant non-small cell lung carcinomas of smokers.
Volm M, Mattern J, Samsel B. Volm M, et al. Br J Cancer. 1991 Oct;64(4):700-4. doi: 10.1038/bjc.1991.384. Br J Cancer. 1991. PMID: 1680367 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical